Skip to main content
Skip to main content
Header Nav
  • About
  • Products
  • Pipeline
  • Impact
  • Investors
  • Careers
  • Contact us
Investors Menu
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Policies and Charters
    • Board Committee Assignments
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Annual Reports
  • Analyst Coverage
  • Investor FAQs
  • Contact IR

Policies and Charters

Policies and Charters

Charter Of The Audit Committee
Anti-Bribery & Anti-Corruption
Code of Business Conduct and Ethics
Charter Of The Disclosure Committee
Insider Trading Policy
Charter of the Nominating and Corporate Governance Committee
Policy for Stockholder Communications with the Board of Directors
Compensation Committee Charter
Compliance Committee Charter
Second Amended Corporate Governance Guidelines - June 2019
Corporate Compliance Program Charter
Window Period Policy
Change % Volume Data as of 01/14/2023 12:30 PM EST Data Provided by Refinitiv. Minimum 15 minutes delayed.
Investor Relations
  • Investor Center Home
  • Press Releases
  • Corporate Governance
    • Board of Directors
    • Leadership Team
    • Policies and Charters
    • Board Committee Assignments
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Stock Quote
    • Investment Calculator
  • SEC Filings
  • Events & Presentations
  • Annual Reports
  • Analyst Coverage
  • Investor FAQs
  • Contact IR
Sidebar Links
  • Email Alerts
  • RSS Feeds

Investor Contact

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.

Footer Links
  • privacy policy
  • terms of use
  • sitemap
  • contact us
© 2023 Eagle Pharmaceuticals, Inc. All rights reserved. Woodcliff Lake, NJ 07677